Kentucky Legislature (healthcare bills) · January 14, 2026 · Primary source
KY HB 196: AN ACT relating to perfluoroalkyl and polyfluoroalkyl substances.
Read the full document at Kentucky Legislature (healthcare bills).
What this may mean
Affects manufacturers of products with intentional PFAS content. Limited impact on healthcare provider or payor operations.
Informational only. Not legal, medical, financial, or other professional advice. Always consult a qualified professional familiar with your specific facts before relying on any item.
Related items
- Kentucky Legislature (healthcare bills) · November 4, 2026KY HJR 24: A JOINT RESOLUTION directing the Cabinet for Health and Family Services to withdraw all waiver applications that have been submitted to the Centers for Medicare and Medicaid Services to establish a community engagement program, and declaring an emergency.Score 85
- Kentucky Legislature (healthcare bills) · October 30, 2026KY HB 21: AN ACT relating to mental health coverage in connection with pregnancy.Score 78
- Kentucky Legislature (healthcare bills) · October 30, 2026KY SB 128: AN ACT relating to prescription drugs.Score 66
- Kentucky Legislature (healthcare bills) · August 20, 2026KY SB 340: AN ACT relating to the Kentucky all-payer claims database.Score 46
- Kentucky Legislature (healthcare bills) · October 30, 2026KY HB 409: AN ACT relating to certificate of need.Score 43
- Kentucky Legislature (healthcare bills) · August 20, 2026KY HB 548: AN ACT relating to informed consent for medical examinations.Score 40